← back to search

Tianxiu Dong

Harbin Medical University · CN
Area of research
Biomedical Engineering · Hepatology
Research interest
Research interests include Cancer research, Hepatocellular carcinoma, Protein kinase B, PI3K/AKT/mTOR pathway, Oncogene, and Apoptosis.
h-index
citations
592
works
25
NIH funding
primary concept
email

Recent publications

The antineoplastic effects of nuciferine on hepatocellular carcinoma are associated with suppression of the HER2-AKT/ERK1/2 signaling pathway
Discover Oncology 2025cited by 2position: middledoi
Melanin@PLGA/Nuciferine Nanoparticles for Enhanced Photothermal Therapy of Hepatocellular Carcinoma by Promoting Autophagy
International Journal of Nanomedicine 2025cited by 2position: middledoi
Correction to: PFP@PLGA/Cu12Sb4S13‑mediated PTT ablates hepatocellular carcinoma by inhibiting the RAS/MAPK/MT‑CO1 signaling pathway
Nano Convergence 2024cited by 1position: firstdoi
Triptonide inhibits growth and metastasis in HCC by suppressing EGFR/PI3K/AKT signaling
Neoplasma 2023cited by 9position: lastdoi
Retraction Note: Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway
Journal of Experimental & Clinical Cancer Research 2023cited by 1position: middledoi
CCL2-targeted ginkgolic acid exerts anti-glioblastoma effects by inhibiting the JAK3-STAT1/PI3K-AKT signaling pathway
Life Sciences 2022cited by 24position: middledoi
Chelerythrine inhibits the progression of glioblastoma by suppressing the TGFB1-ERK1/2/Smad2/3-Snail/ZEB1 signaling pathway
Life Sciences 2022cited by 17position: middledoi
[Retracted] Multifunctional Drug‐Loaded Phase‐Change Nanoparticles Inhibit the Epithelial‐Mesenchymal Transition of Hepatocellular Carcinoma by Affecting the Activity of Activated Hepatic Stellate Cells
BioMed Research International 2022cited by 2position: middledoi
Homoharringtonine inhibits the progression of hepatocellular carcinoma by suppressing the PI3K/AKT/GSK3β/Slug signaling pathway
Neoplasma 2021cited by 12position: middledoi
PFP@PLGA/Cu12Sb4S13-mediated PTT ablates hepatocellular carcinoma by inhibiting the RAS/MAPK/MT-CO1 signaling pathway
Nano Convergence 2021cited by 11position: firstdoi
Polydatin executes anticancer effects against glioblastoma multiforme by inhibiting the EGFR-AKT/ERK1/2/STAT3-SOX2/Snail signaling pathway
Life Sciences 2020cited by 36position: middledoi
Cyclovirobuxine D Exerts Anticancer Effects by Suppressing the <i>EGFR-FAK-AKT/ERK1/2-Slug</i> Signaling Pathway in Human Hepatocellular Carcinoma
DNA and Cell Biology 2020cited by 31position: middledoi
<i>MSH6</i> Aggravates the Hypoxic Microenvironment via Regulating HIF1A to Promote the Metastasis of Glioblastoma Multiforme
DNA and Cell Biology 2020cited by 8position: middledoi
RETRACTED ARTICLE: Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway
Journal of Experimental & Clinical Cancer Research 2019cited by 71position: middledoi
Oncogenic MSH6-CXCR4-TGFB1 Feedback Loop: A Novel Therapeutic Target of Photothermal Therapy in Glioblastoma Multiforme
Theranostics 2019cited by 44position: middledoi
Polydatin inhibits hepatocellular carcinoma via the AKT/STAT3‑FOXO1 signaling pathway
Oncology Letters 2019cited by 29position: middledoi
[Corrigendum] Polydatin inhibits hepatocellular carcinoma via the AKT/STAT3‑FOXO1 signaling pathway
Oncology Letters 2019cited by 3position: middledoi
Up-regulation of MSH6 is associated with temozolomide resistance in human glioblastoma
Biochemical and Biophysical Research Communications 2018cited by 31position: middledoi
The transcription factor Krüppel-like factor 5 promotes cell growth and metastasis via activating PI3K/AKT/Snail signaling in hepatocellular carcinoma
Biochemical and Biophysical Research Communications 2018cited by 25position: middledoi
Ultrasound‑targeted microbubble destruction‑mediated Foxp3 knockdown may suppress the tumor growth of HCC mice by relieving immunosuppressive Tregs function
Experimental and Therapeutic Medicine 2017cited by 27position: middledoi
Hyperthermia with different temperatures inhibits proliferation and promotes apoptosis through the EGFR/STAT3 pathway in C6 rat glioma cells
Molecular Medicine Reports 2017cited by 26position: middledoi
FOXO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial-mesenchymal transition
Oncotarget 2016cited by 111position: firstdoi
Combined effect of ultrasound/SonoVue microbubble on CD4+CD25+ regulatory T cells viability and optimized parameters for its transfection
Ultrasonics 2015cited by 10position: middledoi
The therapies targeting regulatory T ceils
Int J Immunol 2014cited by 0position: firstdoi
Associations Between Infiltrating Lymphocyte Subsets and Hepatocellular Carcinoma
Asian Pacific Journal of Cancer Prevention 2012cited by 59position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xiuhua Yang · Nanchang University18 papers (2014–2025)Yaodong Chen · Harbin Medical University17 papers (2015–2025)Tingting An · Harbin Medical University11 papers (2016–2025)Mingwei Zhu · Harbin Medical University10 papers (2020–2025)Jian Jiang · Harbin Medical University9 papers (2019–2025)Pengfei Liu · Harbin Medical University9 papers (2016–2023)Jiamei Niu · Harbin Medical University8 papers (2020–2025)Zizhuo Li · Kunming University of Science and Technology8 papers (2018–2025)Jiuwei Zhang · Harbin Medical University7 papers (2016–2020)Jian Jiang · Nanchang University7 papers (2019–2025)Yingxuan Mao · Harbin Medical University7 papers (2021–2025)Xi Chen · Harbin Medical University6 papers (2021–2025)Yu Zhang · Harbin Medical University6 papers (2015–2023)Haichao Yang · Harbin Engineering University6 papers (2012–2023)Chunying Shi · Harbin Medical University5 papers (2015–2024)Xiaomeng Zou · Harbin Medical University5 papers (2021–2024)Tiantian Li · Shandong University3 papers (2021–2025)Xiuhua Yang · University of Alabama at Birmingham3 papers (2012–2025)Yingzhe Cui · Harbin Medical University2 papers (2019–2020)Wenjing Zhu · Jiangsu University2 papers (2012–2016)